Discover
FENC
Fennec Pharmaceuticals Inc.
10.34
2 x 7.60
2 x 13.17
bid
ask
-
0.41
3.81%
2 @ 04:00 PM
10.34 +0.00 (0.00%)
| Ytd | 34.29% | |
| 1y | 24.58% |
10.21
day range
10.83
5.65
52 week range
11.31
| Open | 10.71 | Prev Close | 10.75 | Low | 10.21 | High | 10.83 | Mkt Cap | 359.18M |
| Vol | 267.58K | Avg Vol | 273.27K | EPS | -0.29 | P/E | N/A | Forward P/E | 16.78 |
| Beta | 0.27 | Short Ratio | 13.06 | Inst. Own | 54.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 8.67 | 200-d Avg | 8.09 | 1yr Est | 13.60 |
| Income Statement | |||
| Total Revenue | 15.11M | ||
| Revenues (USD) | 15.11M | ||
| Cost of Revenue | 570.00K | ||
| Gross Profit | 14.54M | ||
| Operating Expenses | 14.66M | ||
| Research and Development Expense | 49.00K | ||
| Selling, General and Administrative Expense | 14.61M | ||
| Operating Income | -119.00K | ||
| Interest Expense | 7.00K | ||
| Net Income | 201.00K | ||
| Net Income Common Stock | 201.00K | ||
| Net Income Common Stock (USD) | 201.00K | ||
| Consolidated Income | 201.00K | ||
| Earnings per Basic Share | 0.01 | ||
| Earnings per Basic Share (USD) | 0.01 | ||
| Earnings per Diluted Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 208.00K | ||
| Earning Before Interest & Taxes (USD) | 208.00K | ||
| Weighted Average Shares | 34.34M | ||
| Weighted Average Shares Diluted | 35.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 40.18M | ||
| Cash and Equivalents (USD) | 40.18M | ||
| Trade and Non-Trade Receivables | 23.01M | ||
| Current Assets | 66.88M | ||
| Total Assets | 71.82M | ||
| Current Liabilities | 9.59M | ||
| Total Liabilities | 34.15M | ||
| Accumulated Retained Earnings (Deficit) | -229.22M | ||
| Accumulated Other Comprehensive Income | 1.24M | ||
| Shareholders Equity | 37.67M | ||
| Shareholders Equity (USD) | 37.67M | ||
| Assets Non-Current | 4.94M | ||
| Deferred Revenue | 24.81M | ||
| Inventory | 1.86M | ||
| Liabilities Non-Current | 24.56M | ||
| Trade and Non-Trade Payables | 6.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 26.00K | ||
| Net Cash Flow from Financing | 1.01M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.39M | ||
| Net Cash Flow from Operations | 2.38M | ||
| Share Based Compensation | 990.00K | ||